Cystic Fibrosis #2: Chronic Medications: Changing the Course of Cystic Fibrosis

Module 2 reviews the chronic medications used in CF patients. It will also discuss some of the future directions being explored with medications for CF. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Cystic Fibrosis #3: Management of Acute Pulmonary Exacerbations: Pseudomonas and Beyond

Module 3 addresses the management of infections in CF patients and the use of antibiotics in CF patients. It will review the PK and PD considerations to in these patients. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Cystic Fibrosis #4: Adherence, Access, Education: Current Challenges and Overcoming Barriers in CF Medications

Module 4 discusses the importance of adherence in CF patients and will address the role of education to improve the treatment of CF patients. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Desensitization to Antibiotic Allergies

This activity will use five clinical scenarios to explore treatment options for patients with antibiotic allergies. SIDP Members visit www.SIDP.org/MbrRate for member pricing.

Diagnostics and Antimicrobial Stewardship: How Can We Elevate?

This presentation will focus on the challenges of AMS in European and low/middle income settings, and explain how rapid diagnostics and biomarkers can help to achieve the goals of AMS. The utility of biomarkers for AMS will be examined with an emphasis on the use of PCT.

Dismantling Structural Racism in Pharmacy: Why it Matters to Our Underrepresented Minority Community

This activity will provide key definitions as a basis for discussion of systemic and structural racism in communities and the pharmacy profession. A case study will be used to highlight aspects of this topic and ways to improve the health of the community through diversity, equity and inclusion.

Dueling Recommendations: When to Use Dual Therapy

This presentation will focus on the highlights and recent developments of combination therapy.

Early Antifungals in the ICU: Untangling the Unnecessarily Complex

This activity will focus on antifungals and discuss evidence regarding their use on invasive candidiasis in critically ill patients. Non-culture diagnostic techniques will also be evaluated.

Emerging Practices in the Management of Community-Acquired Bacterial Pneumonia

This continuing education activity will explore the current prevalence and burden of CABP, discuss practice considerations in the use of rapid diagnostics, and examine studies and data surrounding the use of antibiotics currently available as well as emerging agents in the pipeline.

Enhancing Patient Care & Outcomes in the Infectious Disease Setting with Clinically-Integrated Health System Specialty Pharmacy Services

Patients living with HIV, Hepatitis C and other infectious diseases sometimes require specialty medications to manage or treat their conditions. Without appropriate support from their pharmacy, patients may struggle to adhere to their therapy regimens, resulting in subpar clinical outcomes.